Examining CVD in Lupus: Insights from a Diverse Population-Based Registry
Examining CVD in Lupus: Insights from a Diverse Population-Based Registry
Bempedoic acid reduces adverse limb events in patients with PAD
Bempedoic acid reduces adverse limb events in patients with PAD
No benefit of routine spironolactone post-MI
No benefit of routine spironolactone post-MI
Semaglutide reduces MACE in patients with obesity or overweight and prior CABG
Semaglutide reduces MACE in patients with obesity or overweight and prior CABG
Obicetrapib lowers LDL-c on top of other lipid-lowering therapies in HeFH
Obicetrapib lowers LDL-c on top of other lipid-lowering therapies in HeFH
Promising results with oral Lp(a) inhibitor in phase 2 trial
Promising results with oral Lp(a) inhibitor in phase 2 trial
Uncovering Unmet Needs in ATTR Amyloidosis
Uncovering Unmet Needs in ATTR Amyloidosis
Unraveling Hereditary ATTR Amyloidosis: Key Variants and Clinical Insights
Unraveling Hereditary ATTR Amyloidosis: Key Variants and Clinical Insights
Improving Outcomes in hATTR-PN: The Role of Vigilant Symptom Assessment
Improving Outcomes in hATTR-PN: The Role of Vigilant Symptom Assessment
Clinical Perspectives on Prioritizing LDL-C Management After a Recent Coronary Event
Clinical Perspectives on Prioritizing LDL-C Management After a Recent Coronary Event
Prioritizing LDL-C Reduction for Established CVD Patients in Primary Care
Prioritizing LDL-C Reduction for Established CVD Patients in Primary Care
practicaldermatology.com
medicalxpress.com
medicalxpress.com
news-medical.net
medicalxpress.com
news-medical.net
